As of November 2024 Prestige BioPharma has 59.84M shares outstanding, a decrease of -0.41% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 59.84M | -0.41% |
2022 | 60.08M | 16.41% |
2021 | 51.61M | 21.01% |
2020 | 42.65M | - |